4//SEC Filing
Muller Lorenz 4
Accession 0001209191-20-048651
CIK 0001408443other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 5:00 PM ET
Size
7.3 KB
Accession
0001209191-20-048651
Insider Transaction Report
Form 4
Muller Lorenz
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-08-26$1.54/sh+5,700$8,778→ 108,386 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-08-26−5,700→ 49,754 totalExercise: $1.54Exp: 2027-10-11→ Common Stock (5,700 underlying)
Footnotes (1)
- [F1]The original grant was for 140,100 option shares. Twenty-five percent (25%) of the shares subject to the option vested on October 11, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Milestone Pharmaceuticals Inc.
CIK 0001408443
Entity typeother
Related Parties
1- filerCIK 0001771207
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 5:00 PM ET
- Size
- 7.3 KB